Molecular mechanisms underlying the inhi
✍
Na Li; Rebecca C. Salter; Dr. Dipak P. Ramji
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 335 KB
## Abstract PPARs and LXRs are ligand‐activated transcription factors that are emerging as promising therapeutic targets for limiting atherosclerosis, an inflammatory disorder orchestrated by cytokines. The potent anti‐atherogenic actions of these nuclear receptors involve the regulation of glucose